Sanofi declines comment on possible BMS deal
PARIS (Reuters) - French pharmaceuticals group Sanofi (SASY.PA) on Tuesday declined comment on an article in Times newspaper suggesting the group was looking at a merger with Bristol-Myers Squibb (BMY.N).
The spokesman however denied there was a divergence of views between chairman Jean-Francois Le Hecq and chief executive Gerard le Fur, as the Times reported.
There have been regular rumors about a friendly tie-up between the two groups to create a global drugs giant.
- U.S. war veteran released by North Korea returns home |
- Pennsylvania newlyweds "just wanted to murder someone together:" police
- Ice storm causes blackouts, delays in Texas, Arkansas
- WTO overcomes last minute hitch to reach its first global trade deal
- China's parliament: Japan has "no right to criticize" air defense zone
Nelson Mandela: 1918 - 2013
Reuters looks at the life and times of Nelson Mandela, an icon of peace and reconciliation who came to embody the struggle for justice around the world. Video